Developed in 2012 as a treatment for people with type 2 diabetes, Semaglutide took almost 5 years before it was FDA-approved for use
the ability of Regenerons collaborators, licensees, suppliers, or other third parties (as applicable) to perform manufacturing, filling, finishing, packaging, labeling, distribution, and other steps related to Regenerons Products and Regenerons Product Candidates
Most individuals see the most dramatic changes over three to six months of use, along with healthy lifestyle modifications
Its designed to be administered once a week in conjunction with diet and exercise, and has a max dosage of 2 milligrams (mg)
The team, from Harvard and Brigham and Womens Hospital, reviewed the records of patients seen at one Boston neuro-ophthalmology clinic between 2017 and 2023, identified all the patients taking semaglutide for obesity or type 2 diabetes and matched them with patients with those conditions but taking alternative medications
Don't hesitate to reach out to your provider if you: Have been taking semaglutide for several months without seeing significant weight loss progress